Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01850888 Background | Dec 2013 → Oct 2025 | neuroblastoma, pheochromocytoma | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01850888 ↗ |
| Route | Subcutaneous | “G-CSF 5 mcg/kg/day subcutaneously” NCT01850888 ↗ |